03-03-2017 01:13 via articlefeeds.nasdaq.com

Impax (IPXL) Q4 Earnings in Line, Revenues Miss Estimates

Impax Laboratories Inc IPXL posted fourth quarter 2016 adjusted earnings of 16 cents per share in line with the Zacks Consensus Estimate Earnings were also down 74 2 from 62 cents in the year ago period due to lower generic product sales The company s share price fell 34 74 following
Read more »